The U.S. Department of Health and Human Services will work with a team of private industry partners led by Phlow Corporation of Richmond, Virginia, to expand pharmaceutical manufacturing in the United States for use in producing medicines needed during the COVID-19 response and future public health emergencies.
The United States will announce on Tuesday that it has signed a $354 million contract with a company to make generic medicines and pharmaceutical ingredients in the country needed to treat COVID-19, the New York Times reported late on Monday.
SK Holdings, the holding company of South Korea's SK Group, has established SK pharmteco, a U.S.-based Contract Manufacturing Organization (CMO) supporting Pharmaceutical Customers worldwide. This move combines SK biotek in Korea, SK biotek in Ireland, and AMPAC Fine Chemicals (AFC) in the US, to form SK pharmteco, a consolidated CMO. The business is led by Aslam Malik, former CEO of AFC, as Chief Executive Officer, with headquarters in Sacramento, California.
RANCHO CORDOVA, Calif., Feb. 14, 2019 /PRNewswire/ -- AMPAC Fine Chemicals (AFC) is pleased to announce the promotion of Dr. Jeff Butler to the position of Vice President, Project Management and the expansion of Vice President Larry Zeagler's position as the Head of AFC's Operations in Petersburg, Virginia (AFC-VA).
AMPAC Fine Chemicals Moves to Enhance Customer Satisfaction as Don Whiteaker Joins as the Senior Director of Supply Chain
Global Active Pharmaceutical Ingredients Market 2015-2019